|
2015
|
Invention
|
Means and methods for breaking noncovalent binding interactions between molecules. Described are ... |
|
2011
|
Invention
|
Methods of increasing the bioavailability and/or cellular update of drugs.
This invention pertai... |
|
2008
|
Invention
|
Differentiation between brca1-associated and sporadic tumours.
The present invention relates to ... |
|
|
Invention
|
Differentiation between brca1-associated and sporadic tumours. The present invention relates to m... |
|
2007
|
Invention
|
Means and methods for manipulating sequential phagolysomalcytosolic translocation of mycobacteria... |
|
|
Invention
|
Methods for identifying an agent that modulates type i or type ii pip kinase activity or expressi... |
|
2006
|
Invention
|
Prediction of local recurrence of breast cancer.
The invention relates to the field of medicine,... |
|
|
Invention
|
Prediction of local recurrence of breast cancer. The invention relates to the field of medicine, ... |
|
|
Invention
|
Means and methods for manipulating sequential phagolysomal-cytosolic translocation of mycobacteri... |
|
|
Invention
|
Means and methods for breaking noncovalent binding interactions between molecules. The present in... |
|
2005
|
Invention
|
Means and methods for determining and/or influencing transportation. The invention provides a met... |
|
|
Invention
|
Means and methods for detecting and/or staging follicular lymphoma cells.
The invention provides... |
|
|
Invention
|
Means and methods for detecting and/or staging follicular lymphoma cells. The invention provides ... |
|
2004
|
Invention
|
Pharmaceutical formulations employing short-chain sphingolipids and their use. Pharmaceutical for... |
|
|
Invention
|
Pharmaceutical formulations employing short-chain sphingolipids and their use. This invention per... |
|
2002
|
Invention
|
T cell receptor libraries. Strategies for TCR-display that closely mimic the in vivo situation, m... |
|
2001
|
Invention
|
T cell receptor libraries. The present invention provides a strategy for TCR-display that closely... |
|
1999
|
Invention
|
Vectors and methods for providing cells with additional nucleic acid material integrated in the g... |
|
1998
|
Invention
|
Pharmaceutical uses of cdk-2 regulators. The invention relates to substances interfering with pat... |
|
|
Invention
|
Gene targeting and sibling-selection to generate mutant individuals. The invention relates to a m... |
|
1997
|
Invention
|
A family of organic anion transporters, nucleic acids encoding them, cells comprising them and me... |
